FILANA THERAPEUTICS, INC. Balance Sheet
FLNA|5 years of annual SEC 10-K data (FY2011-FY2015)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
FILANA THERAPEUTICS, INC. had $32M in total assets and $48M in shareholders' equity as of FY2015.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.76 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|
| Cash & Equivalents | $48.6M | $49.4M | $73.1M | $4.8M | $35.8M |
| Current Assets | $31.7M | $40.8M | $50.1M | $56.5M | $98.5M |
| PP&E (Net) | $215.0K | $65.0K | - | - | $122.0K |
| Total Assets | $31.9M | $40.9M | $50.1M | $56.9M | $99.0M |
| Current Liabilities | $2.6M | $850.0K | $1.8M | $10.0M | $13.3M |
| Shareholders' Equity | $48.3M | $13.1M | $44.4M | $32.9M | $108.3M |